Study: surgery prior to drug treatment not beneficial in metastasized breast cancer July 06, 2017Vol.40 No.06
Lenvatinib shows positive results vs sorafenib in unresectable hepatocellular carcinoma July 06, 2017Vol.40 No.06
Takeda, Seattle Genetics announce data of ADCETRIS for CD30-positive cutaneous T-cell lymphoma July 06, 2017Vol.40 No.06
Combined modality treatment could be first course for muscle-invasive bladder cancer July 04, 2017Vol.40 No.06
Drugs & Targets FDA approves Vectibix for use in wild-type ras metastatic colorectal cancer June 30, 2017Vol.43 No.26
Drugs & Targets FDA approves flow cytometry test for leukemias and lymphomas June 30, 2017Vol.43 No.26
Drugs & Targets Novartis Kisqali receives positive CHMP opinion for HR+/HER2- locally advanced or metastatic breast cancer June 30, 2017Vol.43 No.26
Drugs & Targets Novartis receives EU approval for Zykadia in ALK-positive advanced non-small cell lung cancer June 30, 2017Vol.43 No.26
